In COVID-19 patients, AREG is significantly upregulated in PBMCs65, monocytes, CD4 T Cells, NK cells, neutrophils, and DCs61, suggesting that upregulation of AREG may be an attempt to ameliorate the severe injury induced by SARS-CoV-2 infection. The gene discussed is CD4; the disease is COVID-19.